Willfact

Willfact is a human von Willebrand factor concentrate used to manage bleeding disorders like von Willebrand disease. This intravenous therapy helps restore normal clotting function. Suitable for patients requiring factor replacement during procedures or acute bleeding episodes. A trusted option for inherited bleeding disorder management.

Human von Willebrand factor is prescribed to treat and prevent bleeding in patients with von Willebrand disease, a condition where blood doesn’t clot properly. It may also be used before surgeries or dental procedures to reduce bleeding risk. This therapy replaces missing or dysfunctional clotting proteins, supporting normal blood coagulation. Often used for acute bleeding episodes or routine prophylaxis.

After administration, von Willebrand factor concentrates help restore clotting ability, reducing prolonged bleeding times. Patients may experience improved bleeding control within hours of infusion. Some report reduced bruising or spontaneous bleeding episodes with regular use. Effects vary based on individual response and condition severity.

Store Willfact as directed, typically refrigerated but not frozen, and use within the specified shelf life. Always check the product for particles or discoloration before use. Administer under medical supervision to monitor for infusion reactions. Keep emergency contact information accessible during treatment.

Avoid mixing with other medications in the same IV line unless approved by a healthcare provider. Certain medications, such as antifibrinolytics or hormonal therapies, may interact with clotting factors—consult a doctor before combining treatments. Alcohol and some herbal supplements can affect blood clotting and should be used cautiously.